Ono Pharmaceutical Co Ltd (OPHLY)
4.542
-0.01
(-0.18%)
USD |
OTCM |
Jul 01, 15:59
Ono Pharmaceutical Gross Profit Margin (Quarterly): 71.92% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 71.92% |
| December 31, 2023 | 76.60% |
| September 30, 2023 | 75.06% |
| June 30, 2023 | 74.86% |
| March 31, 2023 | 75.71% |
| December 31, 2022 | 75.41% |
| September 30, 2022 | 75.66% |
| June 30, 2022 | 74.76% |
| March 31, 2022 | 74.56% |
| December 31, 2021 | 74.25% |
| September 30, 2021 | 73.74% |
| June 30, 2021 | 73.90% |
| March 31, 2021 | 73.88% |
| December 31, 2020 | 71.12% |
| September 30, 2020 | 71.95% |
| June 30, 2020 | 72.55% |
| March 31, 2020 | 73.91% |
| December 31, 2019 | 73.93% |
| September 30, 2019 | 72.09% |
| June 30, 2019 | 71.98% |
| March 31, 2019 | 73.66% |
| December 31, 2018 | 68.32% |
| September 30, 2018 | 70.63% |
| June 30, 2018 | 71.72% |
| March 31, 2018 | 75.26% |
| Date | Value |
|---|---|
| December 31, 2017 | 75.05% |
| September 30, 2017 | 74.64% |
| June 30, 2017 | 75.14% |
| March 31, 2017 | 72.73% |
| December 31, 2016 | 74.63% |
| September 30, 2016 | 72.82% |
| June 30, 2016 | 72.43% |
| March 31, 2016 | 75.88% |
| December 31, 2015 | 72.87% |
| September 30, 2015 | 73.05% |
| June 30, 2015 | 74.15% |
| March 31, 2015 | 70.60% |
| December 31, 2014 | 77.59% |
| September 30, 2014 | 72.55% |
| June 30, 2014 | 73.90% |
| March 31, 2014 | 76.09% |
| December 31, 2013 | 76.19% |
| September 30, 2013 | 77.21% |
| June 30, 2013 | 79.01% |
| March 31, 2013 | 81.17% |
| December 31, 2012 | 77.06% |
| September 30, 2012 | 76.57% |
| June 30, 2012 | 77.58% |
| March 31, 2012 | 78.08% |
| December 31, 2011 | 80.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
71.12%
Minimum
Dec 2020
76.60%
Maximum
Dec 2023
73.99%
Average
73.93%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 63.60% |
| Nxera Pharma Co Ltd | 74.17% |
| PeptiDream Inc | 35.00% |
| Healios KK | -- |
| AnGes Inc | 63.05% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.43% |
| Return on Assets | 14.34% |
| Return on Invested Capital | 16.43% |
| Profit Margin (Quarterly) | 15.46% |
| Operating Margin (Quarterly) | 13.58% |
| Return on Net Operating Assets | 36.51% |